Literature DB >> 12198326

Dietary phytoestrogens and their synthetic structural analogues as calcium channel blockers in human platelets.

Yuliya Dobrydneva1, Roy L Williams, Gary Z Morris, Peter F Blackmore.   

Abstract

Phytoestrogens have been shown to inhibit platelet activation by blocking platelet calcium channels. This study examined the effect of several synthetic derivatives of trans-resveratrol, genistein, and daidzein on platelet free intracellular calcium ([Ca2+]i) elevation in thrombin-activated platelets and the possible mechanisms of this inhibitory effect. Studies were conducted on fresh human platelets from healthy volunteers. The fluorescent dye fura-2 was used to monitor [Ca2+]i in platelets. At 10 microM-resveratrol, triacetyl-trans-resveratrol, and trimethoxy-trans-resveratrol produced, respectively, 57 +/- 4%, 40 +/- 4%, and 21 +/- 1% inhibition; genistein, acetylgenistein, and dihydrogenistein produced 51 +/- 10%, 26 +/- 7%, and 16 +/- 2% inhibition, respectively; daidzein and diacetyldaidzein produced 56 +/- 5% and 45 +/- 10% inhibition of thrombin-induced [Ca2+]i elevation. The inhibitory effect was immediate and appeared to directly affect the calcium influx channels. Phytoestrogen action on [Ca2+]i did not cause alteration in nitric oxide signaling. Tyrosine phosphorylation was not involved in the inhibition of [Ca2+]i elevation by phytoestrogens, because the percent inhibition produced by the tyrosine kinase inhibitor genistein and its inactive analogue daidzein on thrombin-induced and thapsigargin-induced [Ca2+]i elevation was not significantly different for either compound at any concentration tested. Structure-activity relationship studies on this limited set of compounds reveal the requirements for the stilbene pharmacophore for the calcium-blocking activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198326     DOI: 10.1097/00005344-200209000-00009

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  The Use of 3,5,4'-Tri-O-acetylresveratrol as a Potential Pro-drug for Resveratrol Protects Mice from γ-Irradiation-Induced Death.

Authors:  Kazunori Koide; Sami Osman; Amanda L Garner; Fengling Song; Tracy Dixon; Joel S Greenberger; Michael W Epperly
Journal:  ACS Med Chem Lett       Date:  2011-01-25       Impact factor: 4.345

2.  Inhibition of cardiac voltage-gated sodium channels by grape polyphenols.

Authors:  C H R Wallace; I Baczkó; L Jones; M Fercho; P E Light
Journal:  Br J Pharmacol       Date:  2006-10-03       Impact factor: 8.739

3.  Potentiation of carbachol-induced detrusor smooth muscle contractions by beta-adrenoceptor activation.

Authors:  Adam P Klausner; Keith F Rourke; Amy S Miner; Paul H Ratz
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

4.  Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets.

Authors:  L Navarro-Núñez; J Rivera; J A Guerrero; C Martínez; V Vicente; M L Lozano
Journal:  Br J Pharmacol       Date:  2009-10-08       Impact factor: 8.739

5.  Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells.

Authors:  José A Guerrero; Leyre Navarro-Nuñez; María L Lozano; Constantino Martínez; Vicente Vicente; Jonathan M Gibbins; José Rivera
Journal:  Br J Clin Pharmacol       Date:  2007-04-10       Impact factor: 4.335

6.  Glycoprotein Ib activation by thrombin stimulates the energy metabolism in human platelets.

Authors:  Norma Corona de la Peña; Manuel Gutiérrez-Aguilar; Ileana Hernández-Reséndiz; Álvaro Marín-Hernández; Sara Rodríguez-Enríquez
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

7.  3,5,4'-Tri-O-acetylresveratrol Attenuates Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome via MAPK/SIRT1 Pathway.

Authors:  Lijie Ma; Yilin Zhao; Ruixuan Wang; Tingting Chen; Wangping Li; Yandong Nan; Xueying Liu; Faguang Jin
Journal:  Mediators Inflamm       Date:  2015-11-16       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.